Literature DB >> 2356446

Infected wounds and repeated septicemia in a case of factitious illness.

B Castor1, J Ursing, M Aberg, N Pålsson.   

Abstract

During 19 years an assistant nurse, now 35 years old, has been repeatedly treated for several malingered and self-induced disorders escalating to self-mutilation. An ulcer of her right leg never epithelialised in spite of various local treatments and surgical intervention. During repeated attacks of self-induced septicemia altogether 11 different bacterial species were isolated; on 8 occasions Rhodococcus equi. The septicemias were successfully treated with antibiotics. The underlying psychiatric problem, a borderline personality disorder, has not been possible to treat in a conventional manner. Probably due to collaboration between the plastic surgeon and the psychiatrist she has had fewer attendances and shorter hospital stays lately. Her prognosis is still dubious as regards further self-mutilation and other expressions of self-destructive behaviour.

Entities:  

Mesh:

Year:  1990        PMID: 2356446     DOI: 10.3109/00365549009037907

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  4 in total

1.  Nonhealing wound due to Rhodococcus equi in an apparently immunocompetent patient, revealing CD8+ T-lymphocyte deficiency.

Authors:  Eric Denes; Dominique Peignon-Orsoni; François-Xavier Terrade
Journal:  J Clin Microbiol       Date:  2010-09-29       Impact factor: 5.948

2.  Virulence of Rhodococcus equi isolates from patients with and without AIDS.

Authors:  S Takai; Y Sasaki; T Ikeda; Y Uchida; S Tsubaki; T Sekizaki
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

Review 3.  The medically important aerobic actinomycetes: epidemiology and microbiology.

Authors:  M M McNeil; J M Brown
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

4.  Distribution and antimicrobial susceptibility of Rhodococcus equi from clinical specimens.

Authors:  M M McNeil; J M Brown
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.